Auditoría clínica: una herramienta para el seguimiento de errores preanalíticos en el laboratorio / Clinical audit: a tool to monitor pre-analytical errors in the laboratory

El objetivo del trabajo fue evaluar la efectividad de un programa de auditoría clínica para vigilar y reducir la magnitud de errores preanalíticos en el Laboratorio de Guardia de un hospital público de la provincia de Buenos Aires. En un período de 2004 y otro de 2005 se relevaron los diferentes tipos de errores en 11.949 recipientes de muestras de sangre y orina. Se calcularon los indicadores: porcentaje de errores preanalíticos totales en las muestras (% EP), de muestras coaguladas, de recipientes inadecuados, de volumen inadecuado, de muestras hemolizadas, de muestras batidas y de identificación inadecuada. Se capacitó al personal de enfermería. Se asignaron los costos correspondientes a las etapas de obtención y remisión de muestras de la fase preanalítica. El % EP no presentó modificaciones significativas en 2004, mientras que en 2005 sus variaciones acompañaron las de algunos de los restantes indicadores. Los costos correspondientes a errores preanalíticos constituyeron en promedio el 10% de los costos totales de obtención y remisión de muestras en los períodos estudiados. Se concluye que las actividades de capacitación deben realizarse en forma periódica y someterse a seguimiento continuo a fin de obtener disminuciones significativas y perdurables en la magnitud de los errores preanalíticos.

The aim of this study was to evaluate the effectiveness of a clinical audit program to monitor and reduce the magnitude of pre-analytical errors in the Emergency Laboratory of a Buenos Aires Province public hospital. During a 2004 period and another 2005 one, different types of errors were surveyed in 11.949 blood- and urine-sample flasks. The following indicators were calculated: sample pre-analytical error percentage (% PE), as well as percentages corresponding to coagulated samples, inadequate flask use, inadequate flask volume, samples that underwent haemolysis, shaken samples and poor sample identification. Nursing personnel were trained. Costs incurred were allocated to the extraction and delivery stages within the pre-analytical phase. PE % did not show any meaningful changes in 2004, while in 2005 its variations followed those of some of the other indicators. Costs attributed to pre-analytical error represented 10% of total cost of sample extraction and delivery in the periods that were studied. It can be concluded that training courses must be periodically offered and their results monitored on a permanent basis if any significant and long-lasting reduction in the magnitude of pre-analytical errors is to be achieved.

Effects of levosimendan and dobutamine in experimental acute endotoxemia: a preliminary controlled study.

OBJECTIVE: To test the hypothesis that levosimendan increases systemic and intestinal oxygen delivery (DO(2)) and prevents intramucosal acidosis in septic shock. DESIGN: Prospective, controlled experimental study. SETTING: University-based research laboratory. SUBJECTS: Nineteen anesthetized, mechanically ventilated sheep. INTERVENTIONS: Endotoxin-treated sheep were randomly assigned to three groups: control (n=7), dobutamine (10 microg/kg/min, n=6) and levosimendan (100 microg/kg over 10 min followed by 100 microg/kg/h, n=6) and treated for 120 min. MEASUREMENTS AND MAIN RESULTS: After endotoxin administration, systemic and intestinal DO(2) decreased (24.6+/-5.2 vs 15.3+/-3.4 ml/kg/min and 105.0+/-28.1 vs 55.8+/-25.9 ml/kg/min, respectively; p<0.05 for both). Arterial lactate and the intramucosal-arterial PCO(2) difference (DeltaPCO(2)) increased (1.4+/-0.3 vs 3.1+/-1.5 mmHg and 9+/-6 vs 23+/-6 mmHg mmol/l, respectively; p<0.05). Systemic DO(2) was preserved in the dobutamine-treated group (22.3+/-4.7 vs 26.8+/-7.0 ml/min/kg, p=NS) but intestinal DO(2) decreased (98.9+/-0.2 vs 68.0+/-22.9 ml/min/kg, p<0.05) and DeltaPCO(2) increased (12+/-5 vs 25+/-11 mmHg, p<0.05). The administration of levosimendan prevented declines in systemic and intestinal DO(2) (25.1+/-3.0 vs 24.0+/-6.3 ml/min/kg and 111.1+/-18.0 vs 98.2+/-23.1 ml/min/kg, p=NS for both) or increases in DeltaPCO(2) (7+/-7 vs 10+/-8, p=NS). Arterial lactate increased in both the dobutamine and levosimendan groups (1.6+/-0.3 vs 2.5+/-0.7 and 1.4+/-0.4 vs. 2.9+/-1.1 mmol/l, p=NS between groups). CONCLUSIONS: Compared with dobutamine, levosimendan increased intestinal blood flow and diminished intramucosal acidosis in this experimental model of sepsis.

Increased blood flow prevents intramucosal acidosis in sheep endotoxemia: a controlled study.

INTRODUCTION: Increased intramucosal-arterial carbon dioxide tension (PCO2) difference (DeltaPCO2) is common in experimental endotoxemia. However, its meaning remains controversial because it has been ascribed to hypoperfusion of intestinal villi or to cytopathic hypoxia. Our hypothesis was that increased blood flow could prevent the increase in DeltaPCO2. METHODS: In 19 anesthetized and mechanically ventilated sheep, we measured cardiac output, superior mesenteric blood flow, lactate, gases, hemoglobin and oxygen saturations in arterial, mixed venous and mesenteric venous blood, and ileal intramucosal PCO2 by saline tonometry. Intestinal oxygen transport and consumption were calculated. After basal measurements, sheep were assigned to the following groups, for 120 min: (1) sham (n = 6), (2) normal blood flow (n = 7) and (3) increased blood flow (n = 6). Escherichia coli lipopolysaccharide (5 microg/kg) was injected in the last two groups. Saline solution was used to maintain blood flood at basal levels in the sham and normal blood flow groups, or to increase it to about 50% of basal in the increased blood flow group. RESULTS: In the normal blood flow group, systemic and intestinal oxygen transport and consumption were preserved, but DeltaPCO2 increased (basal versus 120 min endotoxemia, 7 +/- 4 versus 19 +/- 4 mmHg; P < 0.001) and metabolic acidosis with a high anion gap ensued (arterial pH 7.39 versus 7.35; anion gap 15 +/- 3 versus 18 +/- 2 mmol/l; P < 0.001 for both). Increased blood flow prevented the elevation in DeltaPCO2 (5 +/- 7 versus 9 +/- 6 mmHg; P = not significant). However, anion-gap metabolic acidosis was deeper (7.42 versus 7.25; 16 +/- 3 versus 22 +/- 3 mmol/l; P < 0.001 for both). CONCLUSIONS: In this model of endotoxemia, intramucosal acidosis was corrected by increased blood flow and so might follow tissue hypoperfusion. In contrast, anion-gap metabolic acidosis was left uncorrected and even worsened with aggressive volume expansion. These results point to different mechanisms generating both alterations.

Intramucosal-arterial Pco2 gradient does not reflect intestinal dysoxia in anemic hypoxia.

BACKGROUND: An increase in intramucosal-arterial Pco2 gradient (DeltaPco2) might be caused by tissue hypoxia or by diminished blood flow. Our hypothesis was that DeltaPco2 should not be altered in anemic hypoxia with preserved blood flow. METHODS: In 18 anesthetized, mechanically ventilated sheep, oxygen transport was stepwise reduced by hemorrhage (hypovolemia, n = 9) or by hemorrhage and simultaneous dextran infusion (hemodilution, n = 9). RESULTS: Hypovolemia and hemodilution produced comparable decreases in systemic and intestinal oxygen transport and uptake. However, mixed venoarterial and mesenteric venoarterial Pco2 gradients and DeltaPco2 were significantly higher in hypovolemia than in hemodilution (25 +/- 5 vs. 10 +/- 2 mm Hg; 21 +/- 6 vs. 10 +/- 5 mm Hg; and 41 +/- 18 vs. 14 +/- 9 mm Hg, respectively; p < 0.01). CONCLUSION: DeltaPco2 did not reflect intestinal dysoxia during Vo2/Do2 dependency attributable to hemodilution. Blood flow seems to be the main determinant of DeltaPco2.